Hyperlipidemias: all 839 studies

Page 2 of 9. Open to participants first (107), then studies with results posted, then the rest; newest registration first within each.

• Impact of Foods on Bile Acids, Metabolites, and InflammationRecruitingNCT05245357Not applicable
• Integrated Diagnosis and Treatment of CKD on OutcomesRecruitingNCT05242055
• Bempedoic Acid Pregnancy Surveillance ProgramRecruitingNCT05103254
• Effect of Fish Oil on Hyperlipidemia and Toxicities in Children and Young Adults With Acute Lymphoblastic LeukemiaRecruitingNCT04209244Not applicable
• Pharmacokinetics of Simvastatin Post Laparoscopic Sleeve Gastrectomy (LSG)RecruitingNCT03571802Phase 4
• Hyperlipidemia Therapy TERCET Zabrze RegistryRecruitingNCT03065543
• Effect of Genes on Rosuvastatin Therapy for HyperlipidemiaAvailableNCT00934258
• Evaluation of Pharmacist Interventions in Lipid Management for Secondary PreventionCompletedNCT06647238Not applicableResults posted
• Implementation of a Peer Leader-facilitated Dyadic InterventionCompletedNCT06643806Not applicableResults posted
• Examination of the Effects of Chromium Levels on Glucose Metabolism, Lipid Metabolism, Morbidity and Mortality Rates in Patients Followed in Intensive Care UnitCompletedNCT06334042Results posted
• Behavior Change Intervention for Cardiovascular Risk Reduction Among People Experiencing HomelessnessCompletedNCT06025721Not applicableResults posted
• Improving How Older Adults at Risk for Cardiovascular Outcomes Are Selected for Care CoordinationCompletedNCT05820295Not applicableResults posted
• EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders)CompletedNCT05742841Phase 4Results posted
• Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.CompletedNCT05425745Phase 3Results posted
• A Study of LY3561774 in Participants With Mixed DyslipidemiaCompletedNCT05256654Phase 2Results posted
• Unmet Social Needs StudyCompletedNCT04977583Not applicableResults posted
• A Study to Assess the Safety, Efficacy and Tolerability of AZD8233 Treatment in Participants With HyperlipidaemiaCompletedNCT04964557Phase 2Results posted
• Effect of Lactose on Blood LipidsCompletedNCT04924530Not applicableResults posted
• Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary SyndromeCompletedNCT04873934Phase 3Results posted
• Lipid Management in Renal Transplant Recipients Using Evolocumab.CompletedNCT04608474Phase 4Results posted
• A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70)CompletedNCT04516291Phase 2Results posted
• Cardiovascular Risk Assessment for Patients With Rheumatoid Arthritis Arthritis:CompletedNCT04488497Not applicableResults posted
• Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID)CompletedNCT04394715Not applicableResults posted
• Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding StudyCompletedNCT04270760Phase 2Results posted
• Evaluating the Efficacy of Pediatric Lipid Screening AlertsCompletedNCT04118348Not applicableResults posted
• Exercise, Sleep Quality and Nocturnal Fat Oxidation in Metabolic SyndromeTerminatedNCT04105218Not applicableResults posted
• The Effect of Farlong® NotoGinseng™ (Ginseng Plus®) on Cholesterol and Blood PressureCompletedNCT04069715Phase 2Results posted
• Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular MedicationsCompletedNCT03973931Not applicableResults posted
• Compare the Efficacy and Safety of Beta-Glucan as Add-On to Statin in Subjects With Hyperlipidemia.CompletedNCT03857256Phase 2Results posted
• Medication Adherence Clinical Decision SupportCompletedNCT03748420Not applicableResults posted
• Effect of Evolocumab on Coronary AtherosclerosisCompletedNCT03689946Phase 3Results posted
• A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease PreventionCompletedNCT03643705Not applicableResults posted
• Phase 2 Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Chylomicronemia Syndrome (FCS)CompletedNCT03360747Phase 2Results posted
• A Study Evaluating the Safety and Efficacy of Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared to Bempedoic Acid, Ezetimibe, and Placebo in Patients Treated With Maximally Tolerated Statin TherapyCompletedNCT03337308Phase 3Results posted
• Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Participants With Hyperlipoproteinemia(a) and Cardiovascular DiseaseCompletedNCT03070782Phase 2Results posted
• Cardiovascular Risk Screening and Risk Reduction in Women VetsCompletedNCT02991534Not applicableResults posted
• Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular RiskCompletedNCT02991118Phase 3Results posted
• Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin IntolerantCompletedNCT02988115Phase 3Results posted
• Effect of Palm Olein Intake on Lipid Profile and Appetite RegulationCompletedNCT02924896Not applicableResults posted
• Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the BloodCompletedNCT02839902Phase 4Results posted
• Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed DyslipidemiaCompletedNCT02833844Phase 3Results posted
• Exploratory Study of the Effect of Omega-3-acid Ethyl Esters (TAK-085) on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated DilationCompletedNCT02824432Phase 4Results posted
• PERIODONTAL DISEASE AND HYPERLIPIDEMIACompletedNCT02808130Results posted
• Orlistat for the Treatment of Type I HyperlipoproteinemiaCompletedNCT02767531Phase 2Results posted
• Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a))CompletedNCT02729025Phase 3Results posted
• Trial of Antroquinonol in Patients With Hypercholesterolemia and HyperlipidemiaCompletedNCT02719028Phase 2Results posted
• Veteran Peer Coaches Optimizing and Advancing Cardiac HealthCompletedNCT02697422Not applicableResults posted
• Self-Assessment Method for Statin Side-effects Or NoceboCompletedNCT02668016Phase 4Results posted
• Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)CompletedNCT02666664Phase 3Results posted
• Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed DyslipidemiaCompletedNCT02662569Phase 3Results posted
• The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Chylomicronemia SyndromeCompletedNCT02658175Phase 3Results posted
• Effects of Use of a Connected Pillbox On Medication AdherenceCompletedNCT02593032Not applicableResults posted
• Tele-Pharmacy Intervention to Improve Treatment AdherenceCompletedNCT02512276Not applicableResults posted
• Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or DyslipidemiaCompletedNCT02458287Phase 3Results posted
• Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics ProfilingCompletedNCT02437084Phase 4Results posted
• Rosuvastatin Adherence App Study in ChinaCompletedNCT02433288Not applicableResults posted
• Acute Microvascular Changes With LDL ApheresisCompletedNCT02388633Results posted
• Specified Drug-use Survey of the Granular Capsule Formulation of Omega-3 Fatty Acid Ethyl Esters: OCEAN3CompletedNCT02285166Results posted
• The SCCS Polypill Pilot TrialCompletedNCT02278471Phase 2Results posted
• Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of EvolocumabCompletedNCT02275156Phase 1Results posted
• A Study of Evacetrapib (LY2484595) in Participants With High CholesterolTerminatedNCT02227784Phase 3Results posted
• Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal AntibodyCompletedNCT02189837Phase 3Results posted
• Evaluation of the Safety and Efficacy of Long-term Use of Omega-3 Fatty Acid Ethyl EstersCompletedNCT02153073Results posted
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to StatinsCompletedNCT02135029Phase 3Results posted
• Safety Study of AEM-28 to Treat Refractory HypercholesterolemiaCompletedNCT02100839Phase 1/2Results posted
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular EventsCompletedNCT02100514Phase 3Results posted
• Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental IllnessCompletedNCT02029989Not applicableResults posted
• Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-3CompletedNCT01984424Phase 3Results posted
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular EventsCompletedNCT01968967Phase 3Results posted
• Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular EventsCompletedNCT01968954Phase 3Results posted
• Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular RiskCompletedNCT01953328Phase 3Results posted
• Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and HyperlipidemiaCompletedNCT01918332Phase 3Results posted
• Effect of Rice Bran and Cooked Navy Beans on Cholesterol Levels in Healthy ChildrenCompletedNCT01911390Not applicableResults posted
• A Mobile Personal Health Record for Behavioral Health HomesCompletedNCT01890226Not applicableResults posted
• Effect Of Capros Supplementation On Cardiovascular Disease Risk Factors In HumansCompletedNCT01858376Not applicableResults posted
• Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed DyslipidemiaCompletedNCT01854918Phase 3Results posted
• Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2CompletedNCT01763918Phase 3Results posted
• Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects -2CompletedNCT01763905Phase 3Results posted
• LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2CompletedNCT01763866Phase 3Results posted
• Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2CompletedNCT01763827Phase 3Results posted
• The Health Access and Recovery Peer ProgramCompletedNCT01725815Not applicableResults posted
• Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or EfavirenzCompletedNCT01695954Phase 1Results posted
• Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 HyperlipoproteinemiaTerminatedNCT01675154Phase 2Results posted
• Translating a Heart Disease Lifestyle Intervention Into the CommunityCompletedNCT01647438Not applicableResults posted
• Sitagliptin Regulation of Intestinal and Hepatic Lipoprotein Particle and Hepatic Glucose Production in HumansCompletedNCT01600703Phase 2/3Results posted
• Veterans Service Organizations and My HealtheVet (MHV)CompletedNCT01597843Not applicableResults posted
• The Medication Metronome Project - Study to Facilitate Follow-up Testing Resulting From Prescribed Medications to Improve Patient Safety and CareCompletedNCT01586897Not applicableResults posted
• Study to Assess the Tolerability and Efficacy of Anacetrapib (MK-0859) Co-Administered With Statin in Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-020)CompletedNCT01524289Phase 3Results posted
• A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With HypercholesterolemiaCompletedNCT01435382Phase 1Results posted
• A Study of LY3015014 in Healthy Participants With Elevated Low Density Lipoprotein CholesterolCompletedNCT01426412Phase 1Results posted
• Prioritized Clinical Decision Support (CDS) to Reduce Cardiovascular RiskCompletedNCT01420016Not applicableResults posted
• Long Term Antihypertensive Exposure and Adverse Metabolic Effects: PEAR Follow-Up StudyCompletedNCT01409434Phase 4Results posted
• Efficacy and Safety of Fermented Barley on Decrement of Body Fat in Obese SubjectsCompletedNCT01402128Phase 2/3Results posted
• A Human Trial to Evaluate the Efficacy and Safety of Aged Garlic Powder on Improvement of Blood Lipids in Subjects With HyperlipidemiaCompletedNCT01402102Phase 2/3Results posted
• A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol LevelsCompletedNCT01388816Phase 2Results posted
• LAPLACE-TIMI 57: Low-density Lipoprotein Cholesterol (LDL-C) Assessment With PCSK9 monoclonaL Antibody Inhibition Combined With Statin thErapyCompletedNCT01380730Phase 2Results posted
• Monoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid LevelsCompletedNCT01375777Phase 2Results posted
• Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant SubjectsCompletedNCT01375764Phase 2Results posted
• Effect of Fenofibrate Conversion on Triglyceride Levels in Patients on Statin TherapyCompletedNCT01280604Not applicableResults posted
• Biosynthesis of PGD2 in VivoCompletedNCT01275300Not applicableResults posted

← Hyperlipidemias overview